Showing results (81-90 of 160) with videos related to
Sort By:
Pageof 16
The Journal of General Virology|January 1, 1976
Detection of simian type-C particles in Mason-Pfizer virus infected culturesM Ahmed, G Schidlovsky, D L Larson, et al.Science (New York, N.Y.)|April 20, 1979
Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activityT P Caruso, A E Takemori, D L Larson, et al.Pain|July 1, 1997
Inhibition of substance P release from spinal cord tissue after pretreatment with capsaicin does not mediate the antinociceptive effect of capsaicin in adult miceV M Goettl, D L Larson, P S Portoghese, et al.Neurochemistry International|May 28, 2010
Transfer of fatty acyl groups from membrane phosphatides to opiate ligandsA Garzon-Aburbeh, A W Lipkowski, D L Larson, et al.Plastic and Reconstructive Surgery|November 12, 1998
Improvement in resource utilization after development of a clinical pathway for patients with pressure ulcersW W Dzwierzynski, K Spitz, A Hartz, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1980
Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamineT P Caruso, D L Larson, P S Portoghese, et al.Journal of Medicinal Chemistry|October 1, 1984
Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissuesL M Sayre, D L Larson, A E Takemori, et al.Plastic and Reconstructive Surgery|March 1, 1992
Elimination of the vertical scar in reduction mammaplastyN J Yousif, D L Larson, J R Sanger, et al.The Journal of Investigative Dermatology|June 1, 1977
An in situ procedure for the biopsy of pressure-wrapped hypertrophic scarsP S Baur, D L Larson, D F Sloan, et al.Journal of Medicinal Chemistry|August 1, 1986
Activity of N-methyl-alpha- and -beta-funaltrexamine at opioid receptorsM S Mohamed, D L Larson, A E Takemori, et al.Pageof 16